The Evolving Landscape of ctDNA Testing Payer Coverage


Cancer diagnosis and treatment is a rapidly evolving area of the healthcare industry to allow for faster or more precise treatment. Through advanced technology, new methods for precision medicine are available to help personalize treatment. One of these newer testing methods in cancer is circulating tumor DNA (ctDNA) tests.

Download this resource to learn more from Amanda DeMarzo, Senior Principal Consultant at Policy Reporter.



We use our own and third parties cookies to improve your experience and our services. If you continue browsing, we take that to mean that you accept their uses and information.